Forgetfulness

 

Chemotherapy has been associated with causing cognitive deficits, such as forgetfulness and an inability to concentrate. This side effect is often referred to as “chemo-brain.” At this time, there are no proven treatments for cognitive deficits associated with chemotherapy. However, the best way to deal with this unpleasant side effect of chemotherapy is to take steps to minimize the impact of forgetfulness and difficulty concentrating on your daily life.

What are cognitive deficits?

Cognitive deficits are problems with thinking, learning, and memory. If you have cognitive deficits, you may be forgetful or have difficulty concentrating.

What causes forgetfulness and an inability to concentrate?

Research has demonstrated that chemotherapy can have a negative impact on cognitive functioning. Long-term (5-year) cancer survivors who had received chemotherapy scored significantly lower on neuropsychologic tests, particularly in the area of verbal memory, compared with those treated with local therapy only (i.e. surgery). The patients who received chemotherapy also reported greater problems with working memory and were more likely to score among the lowest on the Neuropsychological Performance Index. Furthermore, some survivors may experience long-term cognitive deficits associated with systemic chemotherapy.

The way in which chemotherapy causes cognitive deficits is not clear at this time. It may be related to anemia or a direct effect of chemotherapy on brain function. Your problems with memory and concentration may improve once you complete your chemotherapy, but this may take several weeks to months. However, there is also a possibility that these will be long-term problems.

Other factors that contribute to memory and concentration problems include:

  • Aging
  • Depression
  • Menopause
  • Low blood counts
  • Medications
  • Mental and emotional stress of coping with cancer

Can cognitive deficits be treated?

At this time, there are no proven treatments for cognitive deficits associated with chemotherapy. However, research is ongoing to find a treatment that may help relieve this side effect.

Erythropoietin, a chemical produced by the body that stimulates the production of red blood cells, may protect cells in the brain from the damaging effects of chemotherapy. Researchers from the US Oncology trials group studied the effect of erythropoietin compared with a placebo (sugar pill) on cognitive function in 88 patients receiving chemotherapy. While there were no differences in cognitive function at 6 months after chemotherapy, both groups experienced improvement in performance compared with the first time they took the test. The researchers think this may be due to a practice effect, which means the participants may have learned from the first time they were tested.

Some researchers have also suggested that the herbs Gingko biloba and ginseng can improve cognition and mood and the North Central Cancer Treatment Group (NCCTG) is conducting a randomized placebo-controlled trial testing the effects of Gingko biloba on cognitive function in patients with early-stage breast cancer receiving adjuvant chemotherapy.

Also, behavioral interventions may provide some benefit.

What else can I do?

Problems with memory and concentration can be very frustrating. Although there may not be confirmed treatments at this time, there are things you can do to reduce the impact these problems have on your everyday life. Try these tips:

  • Minimize distractions when you need to complete tasks that require concentration.
  • Use a daily organizer to help you remember appointments.
  • Keep a journal of daily events and activities.
  • Carry a notebook, and use it to write down important information that you want to remember.
  • Get plenty of sleep.
  • Exercise daily.
  • Manage stress.
  • Try to keep your brain active (for example by doing cross word puzzles or other activities that keep your brain active)

This content was last modified on February 08, 2008 .
Latest Cancer News
Bone drug has benefits in cancer patients

July 18, 2008 — NEW YORK (Reuters Health) - The bone-strengthening drug zoledronic acid not only reduces fracture risk in patients with cancer that has spread to the bones, it also improves overall survival, according to the results of a retrospective analysis of three large studies.

Thickness of Squamous Cell Cancer Associated with Risk of Recurrences

July 18, 2008 — The thickness of squamous cell carcinoma (SCC) of the skin is directly related to the risk of recurrences. These results were recently published in Lancet Oncology.

"Emotional" writing may help ease cancer pain

July 18, 2008 — NEW YORK (Reuters Health) - Some cancer patients may find that putting their emotions down in writing helps improve their pain and general well-being, a study suggests.

Select news items provided by Reuters Health